Markets:

Overview

News

Currencies

International

Treasuries

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

246.41 +0.28 (+0.11%)

Streaming Delayed Price Updated: 10:06 AM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ascendis Pharma A/S - Ordinary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 03, 2023

Via Benzinga

Dow Up Triple Digits As Second Quarter Kicks Off ↗

April 03, 2023

The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.

Via Talk Markets

Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 03, 2023

Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.

Via Benzinga

Why Ascendis Pharma Stock Is Plunging Today ↗

April 03, 2023

A regulatory hiccup is weighing on the biopharma's shares today.

Via The Motley Fool

Ascendis Pharma Flags Regulatory Delay In US For Its Hypoparathyroidism Candidate ↗

April 03, 2023

Via Benzinga

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet ↗

April 03, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The...

Via Benzinga

Tesla, NIO And Other Big Stocks Moving Lower On Monday ↗

April 03, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application ↗

April 03, 2023

The FDA decision prevents Ascendis from labeling and marketing the new drug application for TransCon PTH. ASND stock plunged

Via Investor's Business Daily

ASND LOSS ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation – ASND

April 03, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Analyst Expectations for Ascendis Pharma's Future ↗

February 03, 2023

Via Benzinga

Where Ascendis Pharma Stands With Analysts ↗

November 29, 2022

Via Benzinga

What 9 Analyst Ratings Have To Say About Ascendis Pharma ↗

November 29, 2022

Via Benzinga

Analyst Ratings for Ascendis Pharma ↗

November 29, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 03, 2023

Via Benzinga

BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study ↗

March 06, 2023

The company is testing a drug for children with achondroplasia, a cause of dwarfism.

Via Investor's Business Daily

Johnson & Johnson: Taking The Bull By The Horns?

February 21, 2023

Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.

Via MarketBeat

Topics Intellectual Property Regulatory Compliance

Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices ↗

January 14, 2023

Qitan Technology, a Chengdu nanopore sequencing company, completed a $101 million Series C round to support its commercialized nanopore devices. Meanwhile, Japan’s Takeda was approved to launch...

Via Talk Markets

Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday ↗

November 14, 2022

U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Ascendis Pharma's Program Hits Primary Goal In Children With Short-Limbed Dwarfism ↗

November 14, 2022

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Analyst Ratings for Ascendis Pharma ↗

November 07, 2022

Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings within the last quarter:

Via Benzinga

6 Analysts Have This to Say About Ascendis Pharma ↗

October 20, 2022

Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings within the last quarter:

Via Benzinga

Expert Ratings for Ascendis Pharma ↗

September 22, 2022

Within the last quarter, Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Ascendis Pharma ↗

August 30, 2022

Analysts have provided the following ratings for Ascendis Pharma (NASDAQ:ASND) within the last quarter:

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 14, 2022

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗

October 20, 2022

Upgrades

Via Benzinga

Ascendis Seeks FDA Nod For TransCon PTH In Adults With Hypoparathyroidism ↗

August 31, 2022

Ascendis Pharma (NASDAQ: ASND) has submitted a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for TransCon PTH, an investigational pro-drug designed to restore parathyroid...

Via Benzinga

Oppenheimer Maintains Outperform Rating for Ascendis Pharma: Here's What You Need To Know ↗

August 11, 2022

Oppenheimer has decided to maintain its Outperform rating of Ascendis Pharma (NASDAQ:ASND) and lower its price target from $154.00 to $144.00. Shares of Ascendis Pharma are trading up 8.7% over the...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.